Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × Panitumumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 35 Colonic Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 11 Neoplasms 10 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Carcinoma, Squamous Cell 4 Breast Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Exanthema 1 Cone Dystrophy 3 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡